The ability of stem cells to differentiate into multiple cell lineages has ushered in exciting
possibilities for stem cell based therapies that would be used to regenerate and repair …

Background aims. Emerging evidence suggests human placental membrane is a valuable
source of mesenchymal stromal cells (MSC). Amnion and chorion are tissues of early …

In addition to the placenta, umbilical cord and amniotic fluid, the amniotic membrane is
emerging as an immensely valuable and easily accessible source of stem and progenitor …

The human amniotic membrane (HAM) is a highly abundant and readily available tissue.
This amniotic tissue has considerable advantageous characteristics to be considered as an …

Mesenchymal stem cells (MSCs) have the ability to differentiate into osteocytes,
chondrocytes, and adipocytes and possess immunomodulatory properties. Amniotic …

Gestational tissue such as the placenta, placental membranes, and amniotic fluid are
usually discarded following birth. Recently, researchers have identified gestational tissue as …

Cellular therapy has emerged as a new potential tool for curing a wide range of
degenerative diseases and tissue necrosis. Embryonic stem cells possess potential for …

Highlights•Regenerative medicine focusses on replacement, repair and regeneration of
cells, tissues and organs.•Amniotic fluid stem cells (AFSCs) are broadly multipotent, that is …

Human amniotic membranes and amniotic fluid have attracted increasing attention in recent
years as a possible reserve of stem cells that may be useful for clinical application in …

Amniotic epithelial cells develop from the epiblast by 8 days after fertilization and before
gastrulation, opening the possibility that they might maintain the plasticity of pregastrulation …